Andreas Busch is one of the most dis­tin­guished research man­agers in the phar­ma­ceut­ical industry. After an aca­demic career in physiology and phar­ma­co­logy in Ger­many and the USA, the phar­macist moved to industry. From 1999 to 2004, he was Vice President/Global Head of Car­di­ovas­cu­lar Research at San­ofi-Aventis in Frankfurt/Main, then until 2017 at Bayer Pharma as a mem­ber of the Bayer Health­Care Board of Man­age­ment and Exec­ut­ive Vice Pres­id­ent and Global Head Drug Dis­cov­ery. From 2018 to 2019 he was Head of R&D and CSO at Shire Phar­ma­ceut­ic­als and since 2019 he has been Chief Innov­a­tion Officer, Cyclerion Inc, Switzerland/USA. Andreas Busch has been Pro­fessor of Phar­ma­co­logy at the Uni­ver­sity of Frank­furt since 2000. He has been and still is a mem­ber of numer­ous advis­ory boards of research insti­tu­tions and com­pan­ies, includ­ing Takeda as well as start-up com­pan­ies such as Omei­cos and Ber­lin­Cures in Berlin.